scholarly journals Beyond access to psychotropic medicines: treatment coverage amid COVID-19

2021 ◽  
Vol 8 (12) ◽  
pp. 1019-1021
Author(s):  
Lola Kola
Keyword(s):  
Treatment Coverage ◽  
Psychotropic Medicines

scholarly journals Predictors of historical change in drug treatment coverage among people who inject drugs in 90 large metropolitan areas in the USA, 1993–2007

2020 ◽  
Vol 15 (1) ◽  
Author(s):  
Barbara Tempalski ◽  
Leslie D. Williams ◽  
Brooke S. West ◽  
Hannah L. F. Cooper ◽  
Stephanie Beane ◽  
...  
Keyword(s):  
Public Health ◽  
Drug Treatment ◽  
Resource Availability ◽  
People Who Inject Drugs ◽  
Census Data ◽  
Poverty Rate ◽  
Community Action ◽  
Historical Change ◽  
Treatment Coverage ◽  
Over Time

Abstract Background Adequate access to effective treatment and medication assisted therapies for opioid dependence has led to improved antiretroviral therapy adherence and decreases in morbidity among people who inject drugs (PWID), and can also address a broad range of social and public health problems. However, even with the success of syringe service programs and opioid substitution programs in European countries (and others) the US remains historically low in terms of coverage and access with regard to these programs. This manuscript investigates predictors of historical change in drug treatment coverage for PWID in 90 US metropolitan statistical areas (MSAs) during 1993–2007, a period in which, overall coverage did not change. Methods Drug treatment coverage was measured as the number of PWID in drug treatment, as calculated by treatment entry and census data, divided by numbers of PWID in each MSA. Variables suggested by the Theory of Community Action (i.e., need, resource availability, institutional opposition, organized support, and service symbiosis) were analyzed using mixed-effects multivariate models within dependent variables lagged in time to study predictors of later change in coverage. Results Mean coverage was low in 1993 (6.7%; SD 3.7), and did not increase by 2007 (6.4%; SD 4.5). Multivariate results indicate that increases in baseline unemployment rate (β = 0.312; pseudo-p < 0.0002) predict significantly higher treatment coverage; baseline poverty rate (β = − 0.486; pseudo-p < 0.0001), and baseline size of public health and social work workforce (β = 0.425; pseudo-p < 0.0001) were predictors of later mean coverage levels, and baseline HIV prevalence among PWID predicted variation in treatment coverage trajectories over time (baseline HIV * Time: β = 0.039; pseudo-p < 0.001). Finally, increases in black/white poverty disparity from baseline predicted significantly higher treatment coverage in MSAs (β = 1.269; pseudo-p < 0.0001). Conclusions While harm reduction programs have historically been contested and difficult to implement in many US communities, and despite efforts to increase treatment coverage for PWID, coverage has not increased. Contrary to our hypothesis, epidemiologic need, seems not to be associated with change in treatment coverage over time. Resource availability and institutional opposition are important predictors of change over time in coverage. These findings suggest that new ways have to be found to increase drug treatment coverage in spite of economic changes and belt-tightening policy changes that will make this difficult.

scholarly journals The role of contraception in preventing HIV-positive births: global estimates and projections

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Jennifer Sherwood ◽  
Elise Lankiewicz ◽  
Beirne Roose-Snyder ◽  
Bergen Cooper ◽  
Austin Jones ◽  
...  
Keyword(s):  
South Africa ◽  
Hiv Infections ◽  
Review Literature ◽  
Hiv Treatment ◽  
Sub Saharan Africa ◽  
Treatment Coverage ◽  
Contraception Use ◽  
Unintended Births ◽  
Mother To Child ◽  
Method Mix

Abstract Background Meeting the contraceptive needs of women living with HIV (WLHIV) has primary health benefits for women, in addition to being a key element to prevent mother-to-child HIV transmission. This analysis will estimate the current number of infant HIV infections prevented by contraception in the era of increased HIV treatment coverage and; 2) model the additional HIV benefits of preventing unintended births to WLHIV. Methods Secondary data analysis was conducted using publicly available data from the United Nations Programme on HIV/AIDS (UNAIDS) and Population Division, Demographic Health Surveys, and peer-review literature. National data from 70 countries, that had a UNAIDS estimate for the number of WLHIV nationally, were combined into country-level models. Models estimated the current number of infant HIV infections averted by contraception annually and potentially averted if unintended births to WLHIV were prevented. Estimates take into account pregnancy and live birth rates, contraceptive coverage, contraceptive method mix and failure rates, and HIV treatment coverage during pregnancy to prevent mother to child transmission. Results Contraception use among WLHIV prevents an estimated 43,559 new infant HIV infections annually across 70 countries. Countries with the largest number of infant infections averted by contraception included South Africa (9441), Nigeria (4195), Kenya (3508), Zimbabwe (2586), and India (2145). Preventing unintended births to WLHIV could avert an additional 43,768 new infant infections per year, with the greatest potential gains to be made in South Africa (12,036), Nigeria (2770), Uganda (2552), and the Democratic Republic of the Congo (2324). Conclusions Contraception continues to play an integral role in global HIV prevention efforts in the era of increasing HIV treatment coverage, especially in sub-Saharan Africa. Broad contraceptive availability, increased contraceptive voluntarism and method mix are key components to preventing unintended births and ending new infant HIV infections worldwide.

scholarly journals How Prolific is Psychotropic Medicines Use in People with Dementia in Australia Within the Community Setting? A Retrospective Analysis

2015 ◽  
Vol 2 (3) ◽  
pp. 289-298 ◽  
Author(s):  
Dianne Goeman ◽  
Kira Harvey ◽  
Cik Yin Lee ◽  
Neil Petrie ◽  
Chris Beanland ◽  
...  
Keyword(s):  
Retrospective Analysis ◽  
Community Setting ◽  
People With Dementia ◽  
Psychotropic Medicines ◽  
Medicines Use

scholarly journals Variation in antiretroviral treatment coverage and virological suppression among three HIV key populations

AIDS ◽  
2018 ◽  
Vol 32 (18) ◽  
pp. 2807-2819 ◽  
Author(s):  
Kamilla Grønborg Laut ◽  
Leah Shepherd ◽  
Magnus Gottfredsson ◽  
Dalibor Sedlacek ◽  
Brygida Knysz ◽  
...  
Keyword(s):  
Antiretroviral Treatment ◽  
Virological Suppression ◽  
Key Populations ◽  
Treatment Coverage

Regulatory meta-analyses for the evaluation of psychotropic medicines

2017 ◽  
Vol 4 (9) ◽  
pp. 660-661 ◽  
Author(s):  
Corrado Barbui ◽  
Marianna Purgato ◽  
Giovanni Ostuzzi
Keyword(s):  
Psychotropic Medicines ◽  
Meta Analyses

scholarly journals Schizophrenia Treatment Coverage Provided by the Public and Private Health Systems of Chile

2020 ◽  
pp. appi.ps.2020000
Author(s):  
Alberto Minoletti ◽  
Gonzalo Soto-Brandt ◽  
Olga Toro ◽  
Matías Irarrázaval ◽  
Rozendo Zanga ◽  
...  
Keyword(s):  
Health Systems ◽  
Public And Private ◽  
Treatment Coverage ◽  
The Public
Sign in / Sign up

Export Citation Format

Share Document